
Venture investor backing food and beverage technology companies, run by finance professionals and former food operators

Technology venture firm investing early in US and Asian companies with cross-Pacific potential

Based in Silicon Valley, H&Q Asia Pacific describes itself as a technology venture investor and a cross-border pioneer in Asia. It says it brought the US venture model to Asia as the first firm of its kind there, and it now has a track record of more than forty years. The firm was founded in 1985 as a division of the investment bank Hambrecht & Quist.
The firm invests early in both the United States and Asia, with a focus on companies that have strong cross-border potential, mainly between Asia and the United States but also in other countries such as Israel. It has managed 29 funds and invested in more than 400 companies since its inception. The company describes its aim as finding commercial opportunities on both sides of the Pacific and working closely with companies to realize their potential there.
Its portfolio includes PhiSkin, a holding company that manages a network of outpatient centers and clinics offering dermatology treatment and medical aesthetic services under the PhiSkin brand. Another example is Senhwa, a Taiwan-based clinical-stage biotechnology company that researches and develops anti-cancer drugs and specialized drug substances.
Over the decades the firm has built a wide local and global network through its portfolio companies and industry relationships. It describes this network as a way of helping future portfolio companies become global businesses, connecting founders with experts, partners and customers across both regions.
H&Q Asia Pacific is a technology venture investment firm based in Silicon Valley with a long record in Asia. It was founded by Dr Ta-lin Hsu as a division of the US bank Hambrecht & Quist. It describes itself as the first US-style venture capital firm in Asia.
The firm works with technology and healthcare companies. Portfolio examples include PhiSkin, a dermatology and medical aesthetics clinic group, and Senhwa, a Taiwan-based biotechnology company developing cancer drugs.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
H&Q Asia Pacific is ranked on 5 TrustList rankings: #1 on 2, #2 on 1 and #3 on 2.
Every ranking orders its listings by their reviews, how complete the profile is and the Trust Score. H&Q Asia Pacific has no reviews yet and 3 of the 10 profile details we look for. Where no listing on a page has been reviewed, the order follows the profiles alone.
It is the only one of the 45 here listing hybrid and one of 2 here listing biotechnology.
Of the 45 here, 6 also cover healthtech and 5 also cover banking; 25 also work in Hong Kong and 14 also work in New York City.
Behind Cedrus Private Equity, ahead of General Atlantic.
It is the only one of the 12 here listing medical and one of 2 here listing banking.
Of the 12 here, 2 also cover growth stage and 2 also cover artificial intelligence; 7 also work in Shanghai and 6 also work in Beijing.
Behind Cedrus Private Equity, ahead of Rayson Technology.
It is the only one of the 25 here listing biotechnology and one of 2 here listing hybrid.
Of the 25 here, 5 also cover partners and 4 also cover private equity; 13 also work in Tokyo and 11 also work in London.
Behind InfraRed, ahead of Daesung Private Equity.
It is the only one of the top 59 here listing biotechnology and one of 2 here listing banking.
Its profile: “Based in Silicon Valley, H&Q Asia Pacific describes itself as a technology venture investor and a cross-border pioneer in Asia.”
Of the top 59 here, 10 also cover seed stage and 10 also cover SaaS; 22 also work in San Francisco and 8 also work in Boston.
Behind Institutional Venture Partners.
It is the only one of the top 59 here listing hybrid and one of 2 here listing biotechnology.
Of the top 59 here, 6 also cover fintech and 5 also cover science.
Behind General Atlantic, ahead of Rayson Technology.
As of 2026-11-16. Organic ranks only; sponsored placements are never ranks. How TrustList ranks
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about H&Q Asia Pacific.
Similar listings buyers compare against this one.

Venture investor backing food and beverage technology companies, run by finance professionals and former food operators

Florida firm providing growth equity and shareholder liquidity to fast-growing private companies

A private investment firm providing liquidity and capital solutions to private companies and their shareholders

Venture investors and operators helping entrepreneurs build technology companies

Real estate and real asset investment and asset management group with a European focus

Healthcare venture growth investor in biotechnology, medical technology and health solutions companies

Chicago-area community banking group offering business and personal banking, mortgages and digital services

Southeast Asian family office that builds and backs technology and internet businesses
Everything here links back to the same verified catalogue. Pick your next stop.